Amicus Therapeutics Inc (FOLD) R&D to Revenue & History | Stock Alarm

Amicus Therapeutics Inc · R&D to Revenue

FOLD R&D to Revenue

Latest reported21.42%period endingDec 31, 2025

FOLD FY R&D/Revenue (0.00% → 21.42%)

Latest values, visible window

High-resolution chart · PNG

FOLD r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Amicus Therapeutics Inc R&D to Revenue — Annual fiscal periods
Period ending	R&D to Revenue
Dec 31, 2025	21.4192%
Dec 31, 2024	20.7009%
Dec 31, 2023	38.1567%
Dec 31, 2022	84.0368%
Dec 31, 2021	89.0463%
Dec 31, 2020	118.229%
Dec 31, 2019	157.1459%
Dec 31, 2018	296.8952%
Dec 31, 2017	404.3054%
Dec 31, 2016	2,113.6144%
Dec 31, 2015	0%
Dec 31, 2014	3,890.8497%
Dec 31, 2013	11,554.8209%
Dec 31, 2012	273.0596%
Dec 31, 2011	237.2679%
Dec 31, 2010	4,234.4902%
Dec 31, 2009	74.7087%
Dec 31, 2008	252.3151%
Dec 31, 2007	1,741.8161%
Dec 31, 2006	0%
Dec 31, 2005	0%
Dec 31, 2004	0%
Dec 31, 2003	0%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.